173 related articles for article (PubMed ID: 36781419)
41. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
[TBL] [Abstract][Full Text] [Related]
42. Emerging therapeutic options for B-cell disorders: idiopathic thrombocytopenic purpura and chronic lymphocytic leukemia.
Goodrich A
Clin J Oncol Nurs; 2007 Feb; 11(1 Suppl):23-36. PubMed ID: 17474175
[TBL] [Abstract][Full Text] [Related]
43. Intracranial hemorrhage in primary immune thrombocytopenia (ITP): 20 years' experience in pediatrics.
Elalfy MS; Eltonbary KYEM; El Ghamry IR; Elalfy O; Wahid M; Badr M; Hassan T; Mansour A; Meabed M; El-Hawy M; Youssry I; Abd Elhady M; Elshanshory M; Elsayh K; Hassab HM
Eur J Pediatr; 2021 May; 180(5):1545-1552. PubMed ID: 33452569
[TBL] [Abstract][Full Text] [Related]
44. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.
Zent CS; Ding W; Reinalda MS; Schwager SM; Hoyer JD; Bowen DA; Jelinek DF; Tschumper RC; Call TG; Shanafelt TD; Kay NE; Slager SL
Leuk Lymphoma; 2009 Aug; 50(8):1261-8. PubMed ID: 19811329
[TBL] [Abstract][Full Text] [Related]
45. Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.
Visco C; Maura F; Tuana G; Agnelli L; Lionetti M; Fabris S; Novella E; Giaretta I; Reda G; Barcellini W; Baldini L; Neri A; Rodeghiero F; Cortelezzi A
Clin Cancer Res; 2012 Apr; 18(7):1870-8. PubMed ID: 22322667
[TBL] [Abstract][Full Text] [Related]
46. Newly diagnosed immune thrombocytopenia adults: Clinical epidemiology, exposure to treatments, and evolution. Results of the CARMEN multicenter prospective cohort.
Moulis G; Germain J; Comont T; Brun N; Dingremont C; Castel B; Arista S; Sailler L; Lapeyre-Mestre M; Beyne-Rauzy O; Godeau B; Adoue D;
Am J Hematol; 2017 Jun; 92(6):493-500. PubMed ID: 28240787
[TBL] [Abstract][Full Text] [Related]
47. Secondary autoimmune cytopenias in chronic lymphocytic leukemia.
Rogers KA; Woyach JA
Semin Oncol; 2016 Apr; 43(2):300-10. PubMed ID: 27040709
[TBL] [Abstract][Full Text] [Related]
48. Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines.
Witmer CM; Lambert MP; O'Brien SH; Neunert C
Pediatr Blood Cancer; 2016 Jul; 63(7):1227-31. PubMed ID: 26929009
[TBL] [Abstract][Full Text] [Related]
49. Why do patients with immune thrombocytopenia (ITP) experience lower bleeding events despite thrombocytopenia?
Boulware R; Refaai MA
Thromb Res; 2020 Mar; 187():154-158. PubMed ID: 32004875
[TBL] [Abstract][Full Text] [Related]
50. Immune thrombocytopenia in chronic myelomonocytic leukemia.
Hadjadj J; Michel M; Chauveheid MP; Godeau B; Papo T; Sacre K
Eur J Haematol; 2014 Dec; 93(6):521-6. PubMed ID: 24913055
[TBL] [Abstract][Full Text] [Related]
51. [Emergency treatment of severe bleeding in immune thrombocytopenia].
Meyer B; Graf L; Endermann S
Anaesthesist; 2021 Jul; 70(7):598-602. PubMed ID: 33728478
[TBL] [Abstract][Full Text] [Related]
52. Severe primary autoimmune thrombocytopenia in pregnancy: a national cohort study.
Care A; Pavord S; Knight M; Alfirevic Z
BJOG; 2018 Apr; 125(5):604-612. PubMed ID: 28432736
[TBL] [Abstract][Full Text] [Related]
53. The presence of idiopathic thrombocytopenic purpura and incidence of acute non-ST elevation myocardial infarction.
Davis M; Movahed MR; Hashemzadeh M; Hashemzadeh M
Ann Hematol; 2022 Jan; 101(1):21-26. PubMed ID: 34596718
[TBL] [Abstract][Full Text] [Related]
54. Development of polycythemia vera and chronic lymphocytic leukemia during the course of refractory idiopathic thrombocytopenic purpura.
Wang G; Ahn YS; Whitcomb CC; Harrington WJ
Cancer; 1984 Apr; 53(8):1770-6. PubMed ID: 6365308
[TBL] [Abstract][Full Text] [Related]
55. Treatment of patients with immune thrombocytopenia admitted to the emergency room.
Bavunoğlu I; Eşkazan AE; Ar MC; Cengiz M; Yavuzer S; Salihoğlu A; Öngören Ş; Tunçkale A; Soysal T
Int J Hematol; 2016 Aug; 104(2):216-22. PubMed ID: 27129318
[TBL] [Abstract][Full Text] [Related]
56. Other immune thrombocytopenias.
Liebman H
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S24-34. PubMed ID: 18096469
[TBL] [Abstract][Full Text] [Related]
57. Risk factors for neonatal thrombocytopenia in pregnancy complicated by idiopathic thrombocytopenic purpura.
Yamada H; Kato EH; Kishida T; Negishi H; Makinoda S; Fujimoto S
Ann Hematol; 1998 May; 76(5):211-4. PubMed ID: 9671135
[TBL] [Abstract][Full Text] [Related]
58. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life.
Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME
J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939
[TBL] [Abstract][Full Text] [Related]
59. Autoimmunity in chronic lymphocytic leukemia.
Ward JH
Curr Treat Options Oncol; 2001 Jun; 2(3):253-7. PubMed ID: 12057125
[TBL] [Abstract][Full Text] [Related]
60. Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia.
Fujimaki K; Takasaki H; Koharazawa H; Takabayashi M; Yamaji S; Baba Y; Kanamori H; Ishigatsubo Y
Leuk Lymphoma; 2005 Jul; 46(7):1101-2. PubMed ID: 16019566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]